Table 3.

Postoperative outcomes for patients undergoing mitral valve operations by operative group.

Outcome	Elective			Urgent/Emergent
	MVR (n=419)	MV Repair (n=673)	P-value	MVR (n=257)	MV Repair (n=128)	P-value
Operative Mortality	7 (1.7%)	5 (0.7%)	0.23	28 (10.9%)	5 (3.9%)	0.03
Major Complication	54 (12.9%)	32 (4.8%)	<0.001	85 (33.1%)	20 (15.6%)	0.001
Myocardial Infarction	0 (0.0%)	0 (0.0%)	N/A	0 (0.0%)	0 (0.0%)	N/A
Stroke	9 (2.1%)	6 (0.9%)	0.11	10 (3.9%)	5 (3.9%)	>0.99
Renal Failure	18 (4.3%)	10 (1.5%)	0.01	27 (10.5%)	3 (2.3%)	0.01
Prolonged Ventilation	44 (10.5%)	22 (3.3%)	<0.001	76 (29.6%)	18 (14.1%)	0.002
Hemodialysis	10 (2.4%)	4 (0.6%)	0.01	17 (6.6%)	0 (0.0%)	0.002
Pneumonia	18 (4.3%)	9 (1.3%)	0.004	20 (7.8%)	5 (3.9%)	0.27
Gastrointestinal Event	11 (2.6%)	2 (0.3%)	0.001	17 (6.6%)	2 (1.6%)	0.04
Sepsis	4 (1.0%)	1 (0.1%)	0.07	16 (6.2%)	3 (1.6%)	0.07
Bleeding or Tamponade	9 (2.1%)	22 (3.3%)	0.35	17 (6.6%)	6 (4.7%)	0.65
Postoperative Length of Stay (Days)	8.8±0.4	5.7±0.2	<0.001	14.1±0.9	9.1±0.9	0.001
ICU Length of Stay (Days)	3.3±0.4	1.9±0.1	<0.001	7.4±0.9	3.4±0.6	0.003
Total Cost ($)	37,793±1,509	24,599±552	<0.001	58,104±3,775	35,522±2,623	<0.001